Michel Auzou

599 total citations
24 papers, 422 citations indexed

About

Michel Auzou is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Michel Auzou has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 8 papers in Epidemiology and 8 papers in Clinical Biochemistry. Recurrent topics in Michel Auzou's work include Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Michel Auzou is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Michel Auzou collaborates with scholars based in France, Italy and United States. Michel Auzou's co-authors include Vincent Cattoir, François Guérin, Roland Leclercq, Jean-Christophe Giárd, M. Vergnaud, Gabriel Auger, Mohamed Sassi, Loren Dejoies, Marguerite Fines-Guyon and Richard Bonnet and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Michel Auzou

24 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Auzou France 14 204 149 142 117 109 24 422
Pia Littauer Denmark 11 158 0.8× 134 0.9× 192 1.4× 141 1.2× 89 0.8× 15 429
Turid Snekloth Søndergaard Denmark 11 267 1.3× 152 1.0× 125 0.9× 159 1.4× 84 0.8× 18 438
Jae Il Yoo South Korea 15 244 1.2× 107 0.7× 185 1.3× 123 1.1× 190 1.7× 29 478
Fei-Fei Gu China 14 168 0.8× 103 0.7× 169 1.2× 97 0.8× 125 1.1× 22 395
Daniela Barbarini Italy 12 191 0.9× 183 1.2× 136 1.0× 130 1.1× 122 1.1× 27 499
Malay Ranjan Sen India 9 226 1.1× 139 0.9× 130 0.9× 85 0.7× 196 1.8× 14 448
Marguerite Fines-Guyon France 12 352 1.7× 212 1.4× 104 0.7× 79 0.7× 139 1.3× 21 494
M.-N. Kim South Korea 12 330 1.6× 113 0.8× 102 0.7× 143 1.2× 145 1.3× 14 532
Shuzhen Xiao China 14 107 0.5× 90 0.6× 221 1.6× 135 1.2× 93 0.9× 29 456
Sabine Camiade France 5 214 1.0× 75 0.5× 148 1.0× 96 0.8× 109 1.0× 7 382

Countries citing papers authored by Michel Auzou

Since Specialization
Citations

This map shows the geographic impact of Michel Auzou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Auzou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Auzou more than expected).

Fields of papers citing papers by Michel Auzou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Auzou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Auzou. The network helps show where Michel Auzou may publish in the future.

Co-authorship network of co-authors of Michel Auzou

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Auzou. A scholar is included among the top collaborators of Michel Auzou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Auzou. Michel Auzou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castagnet, Sophie, Michel Auzou, François Guérin, et al.. (2023). A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds. Scientific Reports. 13(1). 2639–2639. 12 indexed citations
2.
Cordovana, Miriam, Norman Mauder, Markus Kostrzewa, et al.. (2021). Classification of Salmonella enterica of the (Para-)Typhoid Fever Group by Fourier-Transform Infrared (FTIR) Spectroscopy. Microorganisms. 9(4). 853–853. 21 indexed citations
3.
Guérin, François, Michel Auzou, Cécile Le Brun, et al.. (2020). Molecular basis of macrolide-lincosamide-streptogramin (MLS) resistance in Finegoldia magna clinical isolates. Anaerobe. 64. 102220–102220. 5 indexed citations
4.
Isnard, Christophe, Sara B. Hernández, François Guérin, et al.. (2020). Unexpected Cell Wall Alteration-Mediated Bactericidal Activity of the Antifungal Caspofungin against Vancomycin-Resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 64(10). 8 indexed citations
5.
Woerther, Paul‐Louis, Michel Auzou, Élisabeth Chachaty, et al.. (2020). Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in Streptococcus constellatus. Microbial Drug Resistance. 26(7). 727–731. 2 indexed citations
6.
Join‐Lambert, Olivier, Christian Créveuil, Michel Auzou, et al.. (2020). Rothia spp. infective endocarditis: A systematic literature review. Infectious Diseases Now. 51(3). 228–235. 20 indexed citations
7.
Grosset, Noël, et al.. (2020). Isolation of Harveyi clade Vibrio spp. collected in aquaculture farms: How can the identification issue be addressed?. Journal of Microbiological Methods. 180. 106106–106106. 26 indexed citations
8.
Sassi, Mohamed, François Guérin, Racha Beyrouthy, et al.. (2019). Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006–16. Journal of Antimicrobial Chemotherapy. 74(6). 1469–1472. 55 indexed citations
9.
Robin, Frédéric, Michel Auzou, Richard Bonnet, et al.. (2018). In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes. Antimicrobial Agents and Chemotherapy. 62(9). 17 indexed citations
10.
Isnard, Christophe, Anne Dhalluin, Michel Auzou, et al.. (2018). In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Journal of Global Antimicrobial Resistance. 13. 221–225. 14 indexed citations
11.
Castelain, Sandrine, et al.. (2017). Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases. 37(1). 149–155. 15 indexed citations
12.
Pourbaix, Annabelle, François Guérin, Victoire de Lastours, et al.. (2017). Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection. International Journal of Medical Microbiology. 307(8). 452–459. 16 indexed citations
13.
Auzou, Michel, et al.. (2016). Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates. International Journal of Antimicrobial Agents. 48(4). 449–452. 8 indexed citations
14.
Auzou, Michel, et al.. (2016). Sequential steps of daptomycin resistance inEnterococcus faeciumand reversion to hypersusceptibility through IS-mediated inactivation of theliaFSRoperon. Journal of Antimicrobial Chemotherapy. 71(10). 2793–2797. 13 indexed citations
15.
Auzou, Michel, J. Caillon, Claire Poyart, et al.. (2015). In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France. Médecine et Maladies Infectieuses. 45(7). 293–296. 2 indexed citations
16.
Hays, Constantin, Reto Lienhard, Michel Auzou, et al.. (2014). Erm(X)-mediated resistance to macrolides, lincosamides and streptogramins in Actinobaculum schaalii. Journal of Antimicrobial Chemotherapy. 69(8). 2056–2060. 22 indexed citations
17.
Grall, Nathalie, et al.. (2013). Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate. Journal of Antimicrobial Chemotherapy. 68(11). 2464–2467. 13 indexed citations
18.
Bourdon, Nancy, et al.. (2011). In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008. Médecine et Maladies Infectieuses. 41(8). 405–409. 13 indexed citations
19.
Bourdon, Nancy, Astrid Lemire, Marguerite Fines-Guyon, et al.. (2010). Comparison of four methods, including semi-automated rep-PCR, for the typing of vancomycin-resistant Enterococcus faecium. Journal of Microbiological Methods. 84(1). 74–80. 22 indexed citations
20.
Vergnaud, M., et al.. (2000). Macrolide Resistance Phenotypes and Genotypes in French Clinical Isolates of Streptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 19(10). 755–758. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pia Littauer Breakdown of academic impact, for papers by Turid Snekloth Søndergaard Breakdown of academic impact, for papers by Jae Il Yoo Breakdown of academic impact, for papers by Fei-Fei Gu Breakdown of academic impact, for papers by Daniela Barbarini Breakdown of academic impact, for papers by Malay Ranjan Sen Breakdown of academic impact, for papers by Marguerite Fines-Guyon Breakdown of academic impact, for papers by M.-N. Kim Breakdown of academic impact, for papers by Shuzhen Xiao Breakdown of academic impact, for papers by Sabine Camiade
Rankless by CCL
2026